Question
Pharma Shop Ltd. is a mid-sized public company that had been in operation for many years. On December 31, 2023, it had an unlimited number
Pharma Shop Ltd. is a mid-sized public company that had been in operation for many years. On December 31, 2023, it had an unlimited number of common shares authorized and 5.2 million shares issued at an average value of $25 per share. As well, there were 5 million preferred shares authorized, with 250,000 of them issued at $20 per share. The balance in retained earnings was $26,610,000. The balance in accumulated other comprehensive income was $525,000. The preferred shares pay an annual dividend of $2 per share. During 2024, the following transactions affected shareholders equity:
In total, 200,000 new common shares were issued at $30 per share. The preferred dividend for the year was declared and paid. A 10% common stock dividend was declared when the market price was $33 per share. The shares were distributed one month after the declaration. In early December 2024, a dividend of $1.50 per share was declared on the common shares. The date of record was December 15, 2024. The dividend was to be paid the following year. The company earned net income of $14,820,000 and had an other comprehensive loss of $145,000. On December 31, 2024, the company declared a two-for-one stock split on common shares.
a)Use a spreadsheet or table format to track all of the changes in the shareholders equity accounts in 2024.
b)Prepare the statement of changes in shareholders equity for 2024 and the shareholders equity section of the statement of financial position as at the end of 2024. (Hint: the statement of changes in shareholders equity will be similar to the table from part (a) but similar transactions, such as dividends, will be grouped into one line.)
Step by Step Solution
There are 3 Steps involved in it
Step: 1
Get Instant Access to Expert-Tailored Solutions
See step-by-step solutions with expert insights and AI powered tools for academic success
Step: 2
Step: 3
Ace Your Homework with AI
Get the answers you need in no time with our AI-driven, step-by-step assistance
Get Started